Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 6Withdrawn 2Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Pain 2Neoplasm Metastasis 2Bone Neoplasms 2Multiple Myeloma 1Lung Neoplasms 1

Interventions

Morphine 7Fentanyl 5Radiotherapy 4Methadone 4Zoledronic Acid 3Tapentadol 2Ropivacaine 2Pregabalin 2Prednisone 2Ketamine 2Ibandronic Acid 2Hydromorphone 2Glutamine 2Cryotherapy 2Cryosurgery 2Bupivacaine 2Acupuncture Therapy 2Acetaminophen 2pegfilgrastim 1oxycodone naloxone combination 1naloxegol 1ixabepilone 1incobotulinumtoxinA 1imisopasem manganese 1cyclobenzaprine 1cabozantinib 1acetaminophen, aspirin, caffeine drug combination 1Zolpidem 1Surveys and Questionnaires 1Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Pain × Ibandronic Acid × Clear all
NCT00099177 2017-08-16

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Hoffmann-La Roche

Phase 3 Terminated
96 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT00099203 2017-08-16

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Hoffmann-La Roche

Phase 3 Terminated
163 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡